Johnson & Johnson is one of the world’s largest healthcare companies, with divisions focused on pharmaceuticals, medical devices and consumer healthcare products. It has a market cap of 360 billion. Trades on a PE of 22.69, has a dividend yield of 2.50 per cent. Guest Nicholas Sorour, Sasfin Wealth and resident expert Paul Theron from Vestact decide whether Johnson & Johnson hot or not.